title: Release of purine and pyrimidine nucleosides and their catabolites from the perfused rat hindlimb in response to noradrenaline, vasopressin, angiotensin II and sciatic-nerve stimulation.
abstract: Uric acid and uracil were released at constant rates (0.95 and 0.4 nmol/min per g respectively) by the perfused rat hindlimb. Noradrenaline, vasopressin or angiotensin II further increased the release of these substances 2-5-fold, coinciding with increases in both perfusion pressure (vasoconstriction) and O2 uptake. The hindlimb also released, but in lesser amounts, uridine, hypoxanthine, xanthine, inosine and guanosine, and all but hypoxanthine and guanosine were increased during intense vasoconstriction. Uric acid and uracil releases were increased by noradrenaline in a dose-dependent manner. However, the release of these substances did not fully correspond with the dose-dependent increase in O2 uptake and perfusion pressure, where changes in the latter occurred at lower doses of noradrenaline. Sciatic-nerve stimulation (skeletal-muscle contraction) did not increase the release of uracil, uric acid or uridine, but instead increased the release of inosine (7-fold) and hypoxanthine (2-fold). Since the UTP content as well as the UTP/ATP ratio are higher in smooth muscle than in skeletal muscle, it is proposed that release of uric acid and uracil arises from increased metabolism of the respective adenosine and uridine nucleotides during intense constriction of smooth muscle.
authors.affiliation: Department of Biochemistry, University of Tasmania, Hobart, Australia.
authors.forename: M G
authors.initials: MG
authors.lastname: Clark
authors.forename: S M
authors.initials: SM
authors.lastname: Richards
authors.forename: M
authors.initials: M
authors.lastname: Hettiarachchi
authors.forename: J M
authors.initials: JM
authors.lastname: Ye
authors.forename: G J
authors.initials: GJ
authors.lastname: Appleby
authors.forename: S
authors.initials: S
authors.lastname: Rattigan
authors.forename: E Q
authors.initials: EQ
authors.lastname: Colquhoun
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D006614:Hindlimb / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D009705:Nucleosides / Q000378:metabolism*; D010477:Perfusion; D011684:Purine Nucleosides / Q000378:metabolism; D011741:Pyrimidine Nucleosides / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012584:Sciatic Nerve / Q000187:drug effects*; D014498:Uracil / Q000378:metabolism; D014527:Uric Acid / Q000378:metabolism; D014661:Vasoconstriction / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology*
chemical_list: D009705:Nucleosides; D011684:Purine Nucleosides; D011741:Pyrimidine Nucleosides; D014667:Vasopressins; D000804:Angiotensin II; D014527:Uric Acid; D014498:Uracil; D009638:Norepinephrine